Hutch News
Results per Page:
Fred Hutch epidemiologists receive $2.5M grant for first-ever study of therapeutic use for HPV vaccine
Could the preventive vaccine also be a therapy for anogenital precancers?
The HPV cancer vaccine: Are two doses as good as three?
A reduced dosing regimen may increase vaccination adherence, decrease costs
Finding better ways to treat, prevent HPV
Fred Hutch’s Dr. Denise Galloway chairs gathering of the brightest minds to discuss new advances in HPV research – and what’s still needed